{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T20:59:33Z","timestamp":1776891573253,"version":"3.51.2"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2005,5,1]]},"DOI":"10.1038\/nri1604","type":"journal-article","created":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T13:27:28Z","timestamp":1114781248000},"page":"375-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2982,"title":["Mechanisms of type-I- and type-II-interferon-mediated signalling"],"prefix":"10.1038","volume":"5","author":[{"given":"Leonidas C.","family":"Platanias","sequence":"first","affiliation":[]}],"member":"297","reference":[{"key":"BFnri1604_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"Pestka, S., Langer, J. A., Zoon, K. C. & Samuel, C. E. Interferons and their actions. Annu. Rev. Biochem. 56, 727\u2013777 (1987).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnri1604_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","volume":"202","author":"S Pestka","year":"2004","unstructured":"Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8\u201332 (2004).","journal-title":"Immunol. Rev."},{"key":"BFnri1604_CR3","first-page":"S9-4","volume":"24","author":"S Pestka","year":"1997","unstructured":"Pestka, S. The human interferon \u03b1 species and hybrid proteins. Semin. Oncol. 24, S9-4\u2013S9-17 (1997).","journal-title":"Semin. Oncol."},{"key":"BFnri1604_CR4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1089\/jir.2004.24.687","volume":"24","author":"J Chen","year":"2004","unstructured":"Chen, J., Baig, E. & Fish, E. N. Diversity and relatedness among the type I interferons. J. Interfon Cytokine Res. 24, 687\u2013698 (2004).","journal-title":"J. Interfon Cytokine Res."},{"key":"BFnri1604_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0301-472X(99)00109-5","volume":"27","author":"LC Platanias","year":"1999","unstructured":"Platanias, L. C. & Fish, E. N. Signaling pathways activated by interferons. Exp. Hematol. 27, 1583\u20131592 (1999).","journal-title":"Exp. Hematol."},{"key":"BFnri1604_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00001622-200311000-00005","volume":"15","author":"S Parmar","year":"2003","unstructured":"Parmar, S. & Platanias, L. C. Interferons: mechanisms of action and clinical applications. Curr. Opin. Oncol. 15, 431\u2013439 (2003).","journal-title":"Curr. Opin. Oncol."},{"key":"BFnri1604_CR7","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1359-6101(97)00009-9","volume":"8","author":"S Pestka","year":"1997","unstructured":"Pestka, S. et al. The interferon \u03b3 (IFN-\u03b3) receptor: a paradigm for the multichain cytokine receptor. Cytokine Growth Factor Rev. 8, 189\u2013206 (1997).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnri1604_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","volume":"15","author":"EA Bach","year":"1997","unstructured":"Bach, E. A., Aguet, M. & Schreiber, R. D. The IFN \u03b3 receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15, 563\u2013591 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1604_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1098\/rspb.1957.0048","volume":"147","author":"A Isaacs","year":"1957","unstructured":"Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147, 258\u2013267 (1957).","journal-title":"Proc. R. Soc. Lond. B"},{"key":"BFnri1604_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/ni875","volume":"4","author":"SV Kotenko","year":"2003","unstructured":"Kotenko, S. V. et al. IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex. Nature Immunol. 4, 69\u201377 (2003).","journal-title":"Nature Immunol."},{"key":"BFnri1604_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"JE Darnell","year":"1994","unstructured":"Darnell, J. E., Kerr, I. M. & Stark, G. R. Jak\u2013STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins. Science 264, 1415\u20131420 (1994). A comprehensive review of the IFN-activated JAK\u2013STAT-signalling pathways.","journal-title":"Science"},{"key":"BFnri1604_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0065-2776(08)60582-9","volume":"60","author":"JN Ihle","year":"1995","unstructured":"Ihle, J. N. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60, 1\u201335 (1995).","journal-title":"Adv. Immunol."},{"key":"BFnri1604_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0163-7258(03)00016-0","volume":"98","author":"LC Platanias","year":"2003","unstructured":"Platanias, L. C. The p38 mitogen-activated protein kinase pathway and its role in interferon signaling. Pharmacol. Ther. 98, 129\u2013142 (2003).","journal-title":"Pharmacol. Ther."},{"key":"BFnri1604_CR14","doi-asserted-by":"publisher","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","volume":"95","author":"SD Der","year":"1998","unstructured":"Der, S. D., Zhou, A., Williams, B. R. & Silverman, R. H. Identification of genes differentially regulated by interferon \u03b1, \u03b2, or \u03b3 using oligonucleotide arrays. Proc. Natl Acad. Sci. USA 95, 15623\u201315628 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1126\/science.1496401","volume":"257","author":"C Schindler","year":"1992","unstructured":"Schindler, C., Shuai, K., Prezioso, V. R. & Darnell, J. E. Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809\u2013813 (1992).","journal-title":"Science"},{"key":"BFnri1604_CR16","doi-asserted-by":"publisher","first-page":"7840","DOI":"10.1073\/pnas.89.16.7840","volume":"89","author":"XY Fu","year":"1992","unstructured":"Fu, X. Y., Schindler, C., Improta, T., Aebersold, R. & Darnell, J. E. The proteins of ISGF-3, the interferon \u03b1-induced transcriptional activator, define a gene family involved in signal transduction. Proc. Natl Acad. Sci. USA 89, 7840\u20137843 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1126\/science.1281555","volume":"258","author":"K Shuai","year":"1992","unstructured":"Shuai, K., Schindler, C., Prezioso, V. R. & Darnell, J. E. Activation of transcription by IFN-\u03b3: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 258, 1808\u20131812 (1992).","journal-title":"Science"},{"key":"BFnri1604_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/366583a0","volume":"366","author":"O Silvennoinen","year":"1993","unstructured":"Silvennoinen, O., Ihle, J. N., Schlessinger, J. & Levy, D. E. Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 366, 583\u2013585 (1993).","journal-title":"Nature"},{"key":"BFnri1604_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","volume":"67","author":"GR Stark","year":"1998","unstructured":"Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H. & Schreiber, R. D. How cells respond to interferons. Annu. Rev. Biochem. 67, 227\u2013264 (1998).","journal-title":"Annu. Rev. Biochem."},{"key":"BFnri1604_CR20","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1126\/science.277.5332.1630","volume":"277","author":"JE Darnell","year":"1997","unstructured":"Darnell, J. E. Stats and gene regulation. Science 277, 1630\u20131635 (1997). An excellent review of the mechanisms of STAT activation and the regulatory effects of STATs on gene transcription.","journal-title":"Science"},{"key":"BFnri1604_CR21","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1126\/science.1071545","volume":"296","author":"DS Aaronson","year":"2002","unstructured":"Aaronson, D. S. & Horvath C. M. A road map for those who don't know JAK\u2013STAT. Science 296, 1653\u20131655 (2002).","journal-title":"Science"},{"key":"BFnri1604_CR22","doi-asserted-by":"publisher","first-page":"6937","DOI":"10.1128\/MCB.16.12.6937","volume":"16","author":"A Meinke","year":"1996","unstructured":"Meinke, A., Barahmand-Pour, F., Wohrl, S., Stoiber, D. & Decker, T. Activation of different Stat5 isoforms contributes to cell-type-restricted signaling in response to interferons. Mol. Cell. Biol. 16, 6937\u20136944 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR23","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1074\/jbc.275.4.2693","volume":"275","author":"JD Farrar","year":"2000","unstructured":"Farrar, J. D., Smith, J. D., Murphy, T. L. & Murphy, K. M. Recruitment of Stat4 to the human interferon-\u03b1\/\u03b2 receptor requires activated Stat2. J. Biol. Chem. 275, 2693\u20132697 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR24","doi-asserted-by":"publisher","first-page":"26789","DOI":"10.1074\/jbc.M401517200","volume":"279","author":"N Torpey","year":"2004","unstructured":"Torpey, N., Maher, S. E., Bothwell, A. L. & Pober, J. S. Interferon \u03b1 but not interleukin 12 activates STAT4 signaling in human vascular endothelial cells. J. Biol. Chem. 279, 26789\u201326796 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR25","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1182\/blood.V93.6.1980.406k20_1980_1991","volume":"93","author":"S Matikainen","year":"1999","unstructured":"Matikainen, S. et al. Interferon-\u03b1 activates multiple STAT proteins and upregulates proliferation-associated IL-2R\u03b1, c-myc, and pim-1 genes in human T cells. Blood 93, 1980\u20131991 (1999).","journal-title":"Blood"},{"key":"BFnri1604_CR26","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1046\/j.1432-1327.1998.2540514.x","volume":"254","author":"E Fasler-Kan","year":"1998","unstructured":"Fasler-Kan, E., Pansky, A., Wiederkehr, M., Battegay, M. & Heim, M. H. Interferon-\u03b1 activates signal transducers and activators of transcription 5 and 6 in Daudi cells. Eur. J. Biochem. 254, 514\u2013519 (1998).","journal-title":"Eur. J. Biochem."},{"key":"BFnri1604_CR27","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1126\/science.1074900","volume":"297","author":"KB Nguyen","year":"2002","unstructured":"Nguyen, K. B. et al. Critical role for STAT4 activation by type 1 interferons in the interferon-\u03b3 response to viral infection. Science 297, 2063\u20132066 (2002).","journal-title":"Science"},{"key":"BFnri1604_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm, U., Klamp, T., Groot, M. & Howard, J. C. Cellular responses to interferon-\u03b3. Annu. Rev. Immunol. 15, 749\u2013795 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1604_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","volume":"82","author":"Z Wen","year":"1995","unstructured":"Wen, Z., Zhong, Z. & Darnell, J. E. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241\u2013250 (1995).","journal-title":"Cell"},{"key":"BFnri1604_CR30","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1093\/nar\/25.11.2062","volume":"25","author":"Z Wen","year":"1997","unstructured":"Wen, Z. & Darnell, J. E. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25, 2062\u20132067 (1997).","journal-title":"Nucleic Acids Res."},{"key":"BFnri1604_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1074-7613(03)00322-4","volume":"19","author":"L Varinou","year":"2003","unstructured":"Varinou, L. et al. Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-\u03b3-dependent innate immunity. Immunity 19, 793\u2013802 (2003).","journal-title":"Immunity"},{"key":"BFnri1604_CR32","doi-asserted-by":"publisher","first-page":"14408","DOI":"10.1074\/jbc.M109671200","volume":"277","author":"S Uddin","year":"2002","unstructured":"Uddin, S. et al. Protein kinase C-\u03b4 (PKC-\u03b4) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277, 14408\u201314416 (2002). The first identification of PKC-\u03b4 as an IFN-activated kinase that regulates the phosphorylation of STAT1 on Ser727.","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR33","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4049\/jimmunol.171.1.267","volume":"171","author":"DK Deb","year":"2003","unstructured":"Deb, D. K. et al. Activation of protein kinase C \u03b4 by IFN-\u03b3. J. Immunol. 171, 267\u2013273 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1604_CR34","doi-asserted-by":"publisher","first-page":"33637","DOI":"10.1074\/jbc.M301053200","volume":"278","author":"AS Kristof","year":"2003","unstructured":"Kristof, A. S., Marks-Konczalik, J., Billings, E. & Moss, J. Stimulation of signal transducer and activator of transcription-1 (STAT1)-dependent gene transcription by lipopolysaccharide and interferon-\u03b3 is regulated by mammalian target of rapamycin. J. Biol. Chem. 278, 33637\u201333644 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR35","doi-asserted-by":"publisher","first-page":"27399","DOI":"10.1074\/jbc.M403530200","volume":"279","author":"GG Choudhury","year":"2004","unstructured":"Choudhury, G. G. A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase C-\u03b5, and MAPK in mesangial cells regulates interferon-\u03b3-induced STAT1\u03b1 transcriptional activation. J. Biol. Chem. 279, 27399\u201327409 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR36","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1073\/pnas.052159099","volume":"99","author":"JS Nair","year":"2002","unstructured":"Nair, J. S. et al. Requirement of Ca2+ and CaMKII for Stat1 Ser-727 phosphorylation in response to IFN-\u03b3. Proc. Natl Acad. Sci. USA 99, 5971\u20135976 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR37","doi-asserted-by":"publisher","first-page":"15092","DOI":"10.1073\/pnas.93.26.15092","volume":"93","author":"JJ Zhang","year":"1996","unstructured":"Zhang, J. J. et al. Two contact regions between Stat1 and CBP\/p300 in interferon \u03b3 signaling. Proc. Natl Acad. Sci. USA 93, 15092\u201315096 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR38","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/383344a0","volume":"383","author":"S Bhattacharya","year":"1996","unstructured":"Bhattacharya, S. et al. Cooperation of Stat2 and p300\/CBP in signaling induced by interferon-\u03b1. Nature 383, 344\u2013347 (1996).","journal-title":"Nature"},{"key":"BFnri1604_CR39","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1093\/emboj\/17.23.6963","volume":"17","author":"JJ Zhang","year":"1998","unstructured":"Zhang, J. J. et al. Ser727-dependent recruitment of MCM5 by Stat1\u03b1 in IFN-\u03b3-induced transcriptional activation. EMBO J. 17, 6963\u20136971 (1998).","journal-title":"EMBO J."},{"key":"BFnri1604_CR40","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1073\/pnas.061487598","volume":"98","author":"CJ DaFonseca","year":"2001","unstructured":"DaFonseca, C. J., Shu, F. & Zhang, J. J. Identification of two residues in MCM5 critical for the assembly of MCM complexes and Stat1-mediated transcription activation in response to IFN-\u03b3. Proc. Natl Acad. Sci. USA 98, 3034\u20133039 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR41","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1002\/j.1460-2075.1988.tb02956.x","volume":"7","author":"TR Hebbes","year":"1988","unstructured":"Hebbes, T. R., Thorne, A. W. & Crane-Robinson, C. A direct link between core histone acetylation and transcriptionally active chromatin. EMBO J. 7, 1395\u20131402 (1988).","journal-title":"EMBO J."},{"key":"BFnri1604_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/ncb747","volume":"4","author":"M Paulson","year":"2002","unstructured":"Paulson, M., Press, C., Smith, E., Tanese, E. & Levy, D. E. IFN-stimulated transcription through a TBP- free acetyltransferase complex escapes viral shutoff. Nature Cell Biol. 4, 140\u2013147 (2002).","journal-title":"Nature Cell Biol."},{"key":"BFnri1604_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/ncb855","volume":"4","author":"M Huang","year":"2002","unstructured":"Huang, M. et al. Chromatin-remodelling factor BRG1 selectively activates a subset of interferon-\u03b1-inducible genes. Nature Cell Biol. 4, 774\u2013781 (2002).","journal-title":"Nature Cell Biol."},{"key":"BFnri1604_CR44","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0092-8674(00)80965-4","volume":"96","author":"M Zhu","year":"1999","unstructured":"Zhu, M., John, S., Berg, M. & Leonard, W. J. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFN\u03b3-mediated signaling. Cell 96, 121\u2013130 (1999).","journal-title":"Cell"},{"key":"BFnri1604_CR45","doi-asserted-by":"publisher","first-page":"14742","DOI":"10.1073\/pnas.2433987100","volume":"100","author":"I Nusinzon","year":"2003","unstructured":"Nusinzon, I. & Horvath, C. M. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl Acad. Sci. USA 100, 14742\u201314747 (2003). The first evidence that histone-deacetylase activity is required for IFN-dependent transcription.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR46","doi-asserted-by":"publisher","first-page":"9578","DOI":"10.1073\/pnas.0400567101","volume":"101","author":"HM Chang","year":"2004","unstructured":"Chang, H. M. et al. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity. Proc. Natl Acad. Sci. USA 101, 9578\u20139583 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR47","doi-asserted-by":"publisher","first-page":"40362","DOI":"10.1074\/jbc.M406400200","volume":"279","author":"S Sakamoto","year":"2004","unstructured":"Sakamoto, S., Potla, R. & Larner, A. C. Histone deacetylase activity is required to recruit RNA polymerase II to the promoters of selected interferon-stimulated early response genes. J. Biol. Chem. 279, 40362\u201340367 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/332272a0","volume":"332","author":"BJ Mayer","year":"1988","unstructured":"Mayer, B. J., Hamaguchi, M. & Hanafusa, H. A novel viral oncogene with structural homology to phospholipase C. Nature 332, 272\u2013275 (1988).","journal-title":"Nature"},{"key":"BFnri1604_CR49","doi-asserted-by":"publisher","first-page":"6348","DOI":"10.1038\/sj.onc.1204779","volume":"20","author":"SM Feller","year":"2001","unstructured":"Feller, S. M. Crk family adaptors \u2014 signaling complex formation and biological roles. Oncogene 20, 6348\u20136371 (2001).","journal-title":"Oncogene"},{"key":"BFnri1604_CR50","doi-asserted-by":"publisher","first-page":"29991","DOI":"10.1074\/jbc.272.48.29991","volume":"272","author":"S Ahmad","year":"1997","unstructured":"Ahmad, S., Alsayed, Y., Druker, B. J. & Platanias, L. C. The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272, 29991\u201329994 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR51","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.4049\/jimmunol.164.4.1800","volume":"164","author":"Y Alsayed","year":"2000","unstructured":"Alsayed, Y. et al. Interferon-\u03b3 activates the C3G\/Rap1 signaling pathway. J. Immunol. 164, 1800\u20131806 (2000).","journal-title":"J. Immunol."},{"key":"BFnri1604_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0968-0004(03)00087-2","volume":"28","author":"PJ Stork","year":"2003","unstructured":"Stork, P. J. Does Rap1 deserve a bad Rap? Trends Biochem. Sci. 28, 267\u2013275 (2003).","journal-title":"Trends Biochem. Sci."},{"key":"BFnri1604_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/35073073","volume":"2","author":"JL Bos","year":"2001","unstructured":"Bos, J. L., de Rooij, J. & Reedquist, K. A. Rap1 signaling: adhering to new models. Nature Rev. Mol. Cell Biol. 2, 369\u2013377 (2001).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnri1604_CR54","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0092-8674(89)90985-9","volume":"56","author":"H Kitayama","year":"1989","unstructured":"Kitayama, H., Sugimoto, Y., Matsuzaki, T., Ikawa, Y. & Noda, M. A ras-related gene with transformation suppressor activity. Cell 56, 77\u201384 (1989).","journal-title":"Cell"},{"key":"BFnri1604_CR55","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1128\/MCB.21.11.3671-3683.2001","volume":"21","author":"JM Schmitt","year":"2001","unstructured":"Schmitt, J. M. & Stork, P. J. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol. Cell. Biol. 21, 3671\u20133683 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR56","doi-asserted-by":"publisher","first-page":"39356","DOI":"10.1074\/jbc.M304524200","volume":"278","author":"H Lahlou","year":"2003","unstructured":"Lahlou, H. et al. sst2 Somatostatin receptor inhibits cell proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 activation. J. Biol. Chem. 278, 39356\u201339371 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR57","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/jb\/mvg180","volume":"134","author":"M Hattori","year":"2003","unstructured":"Hattori, M. & Minato, N. Rap1 GTPase: functions, regulation and malignancy. J. Biochem. 134, 479\u2013484 (2003).","journal-title":"J. Biochem."},{"key":"BFnri1604_CR58","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1006\/bbrc.2002.6516","volume":"291","author":"F Lekmine","year":"2002","unstructured":"Lekmine, F. et al. The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. Biochem. Biophys. Res. Commun. 291, 744\u2013750 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR59","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0301-472X(99)00060-0","volume":"27","author":"LC Platanias","year":"1999","unstructured":"Platanias, L. C. et al. CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp. Hematol. 27, 1315\u20131321 (1999).","journal-title":"Exp. Hematol."},{"key":"BFnri1604_CR60","doi-asserted-by":"publisher","first-page":"12286","DOI":"10.1074\/jbc.M312868200","volume":"279","author":"CC Huang","year":"2004","unstructured":"Huang, C. C., You, J. L., Wu, M. Y. & Hsu, K. S. Rap1-induced p38 mitogen-activated protein kinase activation facilitates AMPA receptor trafficking via the GDI\u2022Rab5 complex. Potential role in (S)-3,5-dihydroxyphenylglycene-induced long-term depression. J. Biol. Chem. 279, 12286\u201312292 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR61","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni1111","volume":"5","author":"K Katagiri","year":"2004","unstructured":"Katagiri, K. et al. Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking. Nature Immunol. 5, 1045\u20131051 (2004).","journal-title":"Nature Immunol."},{"key":"BFnri1604_CR62","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1074\/jbc.274.2.571","volume":"274","author":"EN Fish","year":"1999","unstructured":"Fish, E. N. et al. Activation of a CrkL\u2013Stat5 signaling complex by type I interferons. J. Biol. Chem. 274, 571\u2013573 (1999). The first report that CRKL forms DNA-binding complexes with STAT5 and functions as a nuclear adaptor for STAT5 in type-I-IFN-mediated signalling.","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1046\/j.1365-2141.2001.02556.x","volume":"112","author":"IM Grumbach","year":"2001","unstructured":"Grumbach, I. M. et al. Engagement of the CrkL adapter in interferon \u03b1 signaling in BCR\u2013ABL expressing cells. Br. J. Haematol. 112, 327\u2013336 (2001).","journal-title":"Br. J. Haematol."},{"key":"BFnri1604_CR64","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/sj.onc.1207533","volume":"23","author":"Y Takahashi","year":"2004","unstructured":"Takahashi, Y., Lallemand-Breitenbach, V., Zhu, J. & de The, H. PML nuclear bodies and apoptosis. Oncogene 23, 2819\u20132824 (2004).","journal-title":"Oncogene"},{"key":"BFnri1604_CR65","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0006-291X(03)01382-2","volume":"308","author":"S Uddin","year":"2003","unstructured":"Uddin, S. et al. Role of Stat5 in type I interferon-signaling and transcriptional regulation. Biochem. Biophys. Res. Commun. 308, 325\u2013330 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR66","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1128\/MCB.19.4.2435","volume":"19","author":"HJ Schaeffer","year":"1999","unstructured":"Schaeffer, H. J. & Weber, M. J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19, 2435\u20132444 (1999).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang, L. & Karin, M. Mammalian MAP kinase signaling cascades. Nature 410, 37\u201340 (2001).","journal-title":"Nature"},{"key":"BFnri1604_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1146\/annurev.immunol.20.091301.131133","volume":"20","author":"C Dong","year":"2002","unstructured":"Dong, C., Davis, R. J. & Flavell, R. A. MAP kinases in the immune response. Annu. Rev. Immunol. 20, 55\u201372 (2002).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1604_CR69","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrm715","volume":"3","author":"CA Hazzalin","year":"2002","unstructured":"Hazzalin, C. A. & Mahadevan, L. C. MAPK-regulated transcription: a continuously variable gene switch? Nature Rev. Mol. Cell Biol. 3, 30\u201340 (2002).","journal-title":"Nature Rev. Mol. Cell Biol."},{"key":"BFnri1604_CR70","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","volume":"101","author":"LC Platanias","year":"2003","unstructured":"Platanias, L. C. Map kinase signaling pathways and hematologic malignancies. Blood 101, 4667\u20134679 (2003).","journal-title":"Blood"},{"key":"BFnri1604_CR71","doi-asserted-by":"publisher","first-page":"30127","DOI":"10.1074\/jbc.274.42.30127","volume":"274","author":"S Uddin","year":"1999","unstructured":"Uddin, S. et al. Activation of the p38 Map kinase by type I interferons. J. Biol. Chem. 274, 30127\u201330131 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR72","doi-asserted-by":"publisher","first-page":"5601","DOI":"10.1093\/emboj\/18.20.5601","volume":"18","author":"KC Goh","year":"1999","unstructured":"Goh, K. C., Haque, S. J. & Williams, B. R. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons. EMBO J. 18, 5601\u20135608 (1999).","journal-title":"EMBO J."},{"key":"BFnri1604_CR73","doi-asserted-by":"publisher","first-page":"27634","DOI":"10.1074\/jbc.M003170200","volume":"275","author":"S Uddin","year":"2000","unstructured":"Uddin, S. et al. The Rac1\/p38 Map kinase pathway is required for IFN\u03b1-dependent transcriptional activation but not serine phosphorylation of Stat-proteins. J. Biol. Chem. 275, 27634\u201327640 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR74","doi-asserted-by":"publisher","first-page":"13956","DOI":"10.1073\/pnas.96.24.13956","volume":"96","author":"P Kovarik","year":"1999","unstructured":"Kovarik, P. et al. Stress-induced phosphorylation of Stat1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-\u03b3 uses a different pathway. Proc. Natl Acad. Sci. USA 96, 13956\u201313961 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR75","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1074\/jbc.M309927200","volume":"279","author":"Y Li","year":"2004","unstructured":"Li, Y. et al. Role of p38\u03b1 Map kinase in type I interferon signaling. J. Biol. Chem. 279, 970\u2013979 (2004). Definitive evidence that the type-I-IFN-activated p38-signalling pathway is required for transcriptional regulation.","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR76","doi-asserted-by":"publisher","first-page":"12859","DOI":"10.1073\/pnas.192264999","volume":"99","author":"K Ramsauer","year":"2002","unstructured":"Ramsauer, K. et al. p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc. Natl Acad. Sci. USA 99, 12859\u201312864 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR77","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/385169a0","volume":"385","author":"P Crespo","year":"1997","unstructured":"Crespo, P., Schuebel, K. E., Ostrom, A. A., Gutkind, J. S. & Bustelo, X. R. Phosphotyrosine-dependent activation of Rac-1 GDP\/GTP exchange by the vav proto-oncogene product. Nature 385, 169\u2013172 (1997).","journal-title":"Nature"},{"key":"BFnri1604_CR78","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1128\/MCB.20.5.1461-1477.2000","volume":"20","author":"XR Bustelo","year":"2000","unstructured":"Bustelo, X. R. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20, 1461\u20131477 (2000).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR79","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1016\/S0021-9258(17)41839-4","volume":"269","author":"LC Platanias","year":"1994","unstructured":"Platanias, L. C. & Sweet, M. E. Interferon \u03b1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem. 269, 3143\u20133146 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR80","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.onc.1203314","volume":"19","author":"A Micouin","year":"2000","unstructured":"Micouin, A., Wietzrbin, J., Steunou, V. & Martyre, M. C. p95Vav is associated to the IFN\u03b1\/\u03b2 receptor and contributes to the antiproliferative effect of IFN\u03b1 in megacaryocytic cell lines. Oncogene 19, 387\u2013394 (2000).","journal-title":"Oncogene"},{"key":"BFnri1604_CR81","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0014-5793(97)00023-9","volume":"403","author":"S Uddin","year":"1997","unstructured":"Uddin, S., Sweet, M. E., Colamonici, O. R., Krolewski, J. J. & Platanias, L. C. The vav proto-oncogene product interacts with the Tyk-2 tyrosine kinase. FEBS Lett. 403, 31\u201334 (1997).","journal-title":"FEBS Lett."},{"key":"BFnri1604_CR82","doi-asserted-by":"publisher","first-page":"10001","DOI":"10.1074\/jbc.M410972200","volume":"280","author":"Y Li","year":"2005","unstructured":"Li, Y. et al. Activation of Mkk3 and Mkk6 by type I interferons. J. Biol. Chem. 280, 10001\u201310010 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR83","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1042\/bst0300959","volume":"30","author":"A Kotlyarov","year":"2002","unstructured":"Kotlyarov, A. & Gaestel, M. Is MK2 (mitogen-activated protein kinase-activated protein kinase 2) the key for understanding post-transcriptional regulation of gene expression? Biochem. Soc. Trans. 30, 959\u2013963 (2002).","journal-title":"Biochem. Soc. Trans."},{"key":"BFnri1604_CR84","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","volume":"17","author":"M Deak","year":"1998","unstructured":"Deak, M., Clifton A. D., Lucocq, L. M. & Alessi, D. R. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB. EMBO J. 17, 4426\u20134441 (1998).","journal-title":"EMBO J."},{"key":"BFnri1604_CR85","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1093\/emboj\/cdg273","volume":"22","author":"A Soloaga","year":"2003","unstructured":"Soloaga, A. et al. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22, 2788\u20132797 (2003).","journal-title":"EMBO J."},{"key":"BFnri1604_CR86","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0014-5793(03)00451-4","volume":"546","author":"AL Clayton","year":"2003","unstructured":"Clayton, A. L. & Mahadevan, L. C. MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett. 546, 51\u201358 (2003).","journal-title":"FEBS Lett."},{"key":"BFnri1604_CR87","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","volume":"16","author":"AJ Waskiewicz","year":"1997","unstructured":"Waskiewicz, A. J., Flynn, A., Proud, C. G. & Cooper, J. A. Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909\u20131920 (1997).","journal-title":"EMBO J."},{"key":"BFnri1604_CR88","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1128\/MCB.21.16.5500-5511.2001","volume":"21","author":"U Knauf","year":"2001","unstructured":"Knauf, U., Tschopp, C. & Gram, H. Negative regulation of protein translation by mitogen-activated protein kinase-interacting kinases 1 and 2. Mol. Cell. Biol. 21, 5500\u20135511 (2001).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR89","doi-asserted-by":"publisher","first-page":"28570","DOI":"10.1074\/jbc.M011685200","volume":"276","author":"IA Mayer","year":"2001","unstructured":"Mayer, I. A. et al. The p38 MAPK pathway mediates the growth inhibitory effects of interferon-\u03b1 in BCR\u2013ABL-expressing cells. J. Biol. Chem. 276, 28570\u201328577 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR90","doi-asserted-by":"publisher","first-page":"7726","DOI":"10.1074\/jbc.M106640200","volume":"277","author":"A Verma","year":"2002","unstructured":"Verma, A. et al. Activation of the p38 Map kinase pathway mediates the suppressive effects of type I interferons and transforming growth factor \u03b2 on normal hematopoiesis. J. Biol. Chem. 277, 7726\u20137735 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR91","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.bbrc.2004.07.015","volume":"321","author":"H Ishida","year":"2004","unstructured":"Ishida, H. et al. Involvement of p38 signaling pathway in interferon-\u03b1-mediated antiviral activity towards hepatitis C virus. Biochem. Biophys. Res. Commun. 321, 722\u2013727 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR92","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nri888","volume":"2","author":"MG Katze","year":"2002","unstructured":"Katze, M. G., He, Y. & Gale, M. Viruses and interferon: a fight for supremacy. Nature Rev. Immunol. 2, 675\u2013687 (2002). An excellent review of the mechanisms by which IFNs mediate antiviral effects.","journal-title":"Nature Rev. Immunol."},{"key":"BFnri1604_CR93","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1126\/science.7569900","volume":"269","author":"M David","year":"1995","unstructured":"David, M. et al. Requirement for MAP kinase (ERK2) activity in interferon \u03b1- and interferon \u03b2-stimulated gene expression through STAT proteins. Science 269, 1721\u20131723 (1995).","journal-title":"Science"},{"key":"BFnri1604_CR94","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1074\/jbc.M004885200","volume":"276","author":"J Hu","year":"2001","unstructured":"Hu, J. et al. ERK1 and ERK2 activate CCAAAT\/enhancer-binding protein-\u03b2-dependent gene transcription in response to interferon-\u03b3. J. Biol. Chem. 276, 287\u2013297 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR95","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/ni1132","volume":"5","author":"F Wang","year":"2004","unstructured":"Wang, F. et al. Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nature Immunol. 5, 1266\u20131274 (2004).","journal-title":"Nature Immunol."},{"key":"BFnri1604_CR96","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1073\/pnas.122075799","volume":"99","author":"SK Roy","year":"2002","unstructured":"Roy, S. K. et al. MEKK1 plays a critical role in activating the transcription factor C\/EBP-\u03b2-dependent gene expression in response to IFN-\u03b3. Proc. Natl Acad. Sci. USA 99, 7945\u20137950 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR97","doi-asserted-by":"publisher","first-page":"12626","DOI":"10.1074\/jbc.275.17.12626","volume":"275","author":"SK Roy","year":"2000","unstructured":"Roy, S. K., Wachira, S. J., Weihua, X., Hu, J. & Kalvakolanu, D. V. CCAAT\/enhancer-binding protein-\u03b2 regulates interferon-induced transcription through a novel element. J. Biol. Chem. 275, 12626\u201312632 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR98","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1074\/jbc.M108473200","volume":"277","author":"ZE Floyd","year":"2002","unstructured":"Floyd, Z. E. & Stephens, J. M. Interferon-\u03b3-mediated activation and ubiquitin-proteasome-dependent degradation of PPAR\u03b3 in adipocytes. J. Biol. Chem. 277, 4062\u20134068 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR99","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/sj.onc.1207273","volume":"23","author":"C Li","year":"2004","unstructured":"Li, C. et al. IFN\u03b1 induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras\u2013Erk signaling. Oncogene 23, 1608\u20131617 (2004).","journal-title":"Oncogene"},{"key":"BFnri1604_CR100","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1074\/jbc.M305893200","volume":"279","author":"G Li","year":"2004","unstructured":"Li, G., Xiang, Y., Sabapathy, K. & Silverman, R. H. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J. Biol. Chem. 279, 1123\u20131131 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR101","doi-asserted-by":"publisher","first-page":"15938","DOI":"10.1074\/jbc.270.27.15938","volume":"270","author":"S Uddin","year":"1995","unstructured":"Uddin, S. et al. Interferon-\u03b1 engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3\u2032-kinase. J. Biol. Chem. 270, 15938\u2013159341 (1995).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR102","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1092952","volume":"302","author":"MF White","year":"2003","unstructured":"White, M. F. Insulin signaling in health and disease. Science 302, 1710\u20131711 (2003).","journal-title":"Science"},{"key":"BFnri1604_CR103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1074\/jbc.271.1.278","volume":"271","author":"LC Platanias","year":"1996","unstructured":"Platanias, L. C. et al. The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J. Biol. Chem. 271, 278\u2013282 (1996).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR104","doi-asserted-by":"publisher","first-page":"24183","DOI":"10.1074\/jbc.272.39.24183","volume":"272","author":"MS Burfoot","year":"1997","unstructured":"Burfoot, M. S. et al. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J. Biol. Chem. 272, 24183\u201324190 (1997).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR105","first-page":"2574","volume":"90","author":"S Uddin","year":"1997","unstructured":"Uddin, S. et al. The IRS-pathway operates distinctively from the Stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-\u03b1 receptors. Blood 90, 2574\u20132582 (1997).","journal-title":"Blood"},{"key":"BFnri1604_CR106","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/bbrc.2000.2402","volume":"270","author":"S Uddin","year":"2000","unstructured":"Uddin, S. et al. Interferon-dependent activation of the serine kinase PI 3\u2032-kinase requires engagement of the IRS pathway but not the Stat pathway. Biochem. Biophys. Res. Commun. 270, 158\u2013162 (2000).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR107","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.4049\/jimmunol.158.5.2390","volume":"158","author":"S Uddin","year":"1997","unstructured":"Uddin, S. et al. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-\u03b1. J. Immunol. 158, 2390\u20132397 (1997).","journal-title":"J. Immunol."},{"key":"BFnri1604_CR108","doi-asserted-by":"publisher","first-page":"27969","DOI":"10.1074\/jbc.274.39.27969","volume":"274","author":"KA Cengel","year":"1999","unstructured":"Cengel, K. A. & Freund, G. G. JAK1-dependent phosphorylation of insulin receptor substrate-1 (IRS-1) is inhibited by IRS-1 serine phosphorylation. J. Biol. Chem. 274, 27969\u201327974 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR109","doi-asserted-by":"publisher","first-page":"33361","DOI":"10.1074\/jbc.M105070200","volume":"276","author":"H Nguyen","year":"2001","unstructured":"Nguyen, H., Ramana, C. V., Bayes, J. & Stark, G. R. Roles of phosphatidylinositol 3-kinase in interferon-\u03b3-dependent phosphorylation of STAT1 on serine 727 and activation of gene expression. J. Biol. Chem. 276, 33361\u201333368 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR110","doi-asserted-by":"publisher","first-page":"45603","DOI":"10.1074\/jbc.M407448200","volume":"279","author":"TA DeVries","year":"2004","unstructured":"DeVries, T. A., Rachelle, L., Kalkofen, A., Matassa, A. & Reyland, M. E. Protein kinase C\u03b4 regulates apoptosis via activation of STAT1. J. Biol. Chem. 279, 45603\u201345612 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR111","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1128\/MCB.17.6.3418","volume":"17","author":"Z Lu","year":"1997","unstructured":"Lu, Z. et al. Tumor promotion by depleting cells of protein kinase C-\u03b4. Mol. Cell. Biol. 17, 3418\u20133428 (1997).","journal-title":"Mol. Cell. Biol."},{"key":"BFnri1604_CR112","first-page":"5710","volume":"59","author":"PJ Redding","year":"1999","unstructured":"Redding, P. J. et al. Transgenic mice overexpressing protein kinase C \u03b4 in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 59, 5710\u20135718 (1999).","journal-title":"Cancer Res."},{"key":"BFnri1604_CR113","doi-asserted-by":"publisher","first-page":"29911","DOI":"10.1074\/jbc.M401997200","volume":"279","author":"KK Srivastava","year":"2004","unstructured":"Srivastava, K. K. et al. Engagement of protein kinase C-\u03b8 in interferon signaling in T-cells. J. Biol. Chem. 279, 29911\u201329920 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR114","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Rev. Cancer 2, 489\u2013501 (2002).","journal-title":"Nature Rev. Cancer"},{"key":"BFnri1604_CR115","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(03)00160-7","volume":"139","author":"O Barca","year":"2003","unstructured":"Barca, O. et al. Interferon \u03b2 promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 139, 155\u2013159 (2003).","journal-title":"J. Neuroimmunol."},{"key":"BFnri1604_CR116","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1006\/bbrc.2001.5025","volume":"284","author":"K Ruuth","year":"2001","unstructured":"Ruuth, K., Carlsson, L., Hallberg, B. & Lundgren, E. Interferon-\u03b1 promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 284, 583\u2013586 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR117","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.4049\/jimmunol.171.2.1035","volume":"171","author":"K Wang","year":"2003","unstructured":"Wang, K. et al. Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-\u03b4, and NF-\u03baB signaling pathways. J. Immunol. 171, 1035\u20131041 (2003).","journal-title":"J. Immunol."},{"key":"BFnri1604_CR118","doi-asserted-by":"publisher","first-page":"13756","DOI":"10.1074\/jbc.M011006200","volume":"276","author":"CH Yang","year":"2001","unstructured":"Yang, C. H. et al. Interferon \u03b1\/\u03b2 promotes cell survival by activating nuclear factor \u03baB through phosphatidylinositol 3-kinase and Akt. J. Biol. Chem. 276, 13756\u201313761 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR119","doi-asserted-by":"publisher","first-page":"24152","DOI":"10.1074\/jbc.M312219200","volume":"279","author":"L Thyrell","year":"2004","unstructured":"Thyrell, L. et al. Interferon \u03b1-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase\/mammalian target of rapamycin signaling pathway. J. Biol. Chem. 279, 24152\u201324162 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR120","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.bbrc.2004.04.082","volume":"318","author":"SY Hwang","year":"2004","unstructured":"Hwang, S. Y. et al. LY294002 inhibits interferon-\u03b3-stimulated inducible nitric oxide synthase expression in BV2 microglial cells. Biochem. Biophys. Res. Commun. 318, 691\u2013697 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnri1604_CR121","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1189\/jlb.1002508","volume":"73","author":"A Navarro","year":"2003","unstructured":"Navarro, A., Anand-Apte, B., Tanabe, Y., Feldman, G. & Larner, A. C. A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J. Leukoc. Biol. 73, 540\u2013545 (2003).","journal-title":"J. Leukoc. Biol."},{"key":"BFnri1604_CR122","doi-asserted-by":"publisher","first-page":"38456","DOI":"10.1074\/jbc.M203204200","volume":"277","author":"MR Rani","year":"2002","unstructured":"Rani, M. R., Hibbert, L., Sizemore, N., Stark, G. R. & Ransohoff, R. M. Requirement of phosphoinositide 3-kinase and Akt for interferon-\u03b2-mediated induction of the \u03b2-R1 (SCYB11) gene. J. Biol. Chem. 277, 38456\u201338461 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR123","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/0042-6822(66)90126-7","volume":"30","author":"PI Marcus","year":"1966","unstructured":"Marcus, P. I. & Salb, J. M. Molecular basis of interferon action: inhibition of viral RNA translation. Virology 30, 502\u2013516 (1966).","journal-title":"Virology"},{"key":"BFnri1604_CR124","doi-asserted-by":"publisher","first-page":"5107","DOI":"10.1210\/endo.142.12.8524","volume":"142","author":"F Doualla-Bell","year":"2001","unstructured":"Doualla-Bell, F. & Koromilas, A. E. Induction of PG G\/H synthase-2 in bovine myometrial cells by interferon-\u03c4 requires the activation of the p38 MAPK pathway. Endocrinology 142, 5107\u20135115 (2001).","journal-title":"Endocrinology"},{"key":"BFnri1604_CR125","doi-asserted-by":"publisher","first-page":"27772","DOI":"10.1074\/jbc.M301364200","volume":"278","author":"F Lekmine","year":"2003","unstructured":"Lekmine, F. et al. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. J. Biol. Chem. 278, 27772\u201327780 (2003). The first report that type I IFNs activate pathways for the initiation of mRNA translation that are downstream of MTOR.","journal-title":"J. Biol. Chem."},{"key":"BFnri1604_CR126","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.yexcr.2003.12.021","volume":"295","author":"F Lekmine","year":"2004","unstructured":"Lekmine, F. et al. Interferon-\u03b3 engages the p70 S6 kinase to regulate phosphorylation of the 40S S6 ribosomal protein. Exp. Cell Res. 295, 173\u2013182 (2004).","journal-title":"Exp. Cell Res."},{"key":"BFnri1604_CR127","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay, N. & Sonenberg, N. Upstream and downstream of mTOR. Genes Dev. 18, 1926\u20131945 (2004). A comprehensive review of MTOR and the regulation of signals for mRNA translation.","journal-title":"Genes Dev."},{"key":"BFnri1604_CR128","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrc1362","volume":"4","author":"MA Bjornsti","year":"2004","unstructured":"Bjornsti, M. A. & Houghton, P. J. The TOR pathway: a target for cancer therapy. Nature Rev. Cancer 4, 335\u2013348 (2004).","journal-title":"Nature Rev. Cancer"},{"key":"BFnri1604_CR129","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1101\/gad.912401","volume":"15","author":"AC Gingras","year":"2001","unstructured":"Gingras, A. C. et al. Hierarchical phosphorylation of the translation inhibitor 4E-BP1. Genes Dev. 15, 2852\u20132864 (2001).","journal-title":"Genes Dev."},{"key":"BFnri1604_CR130","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2004-06-2078","volume":"105","author":"L Lal","year":"2005","unstructured":"Lal, L. et al. Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells. Blood 105, 1669\u20131677 (2005).","journal-title":"Blood"},{"key":"BFnri1604_CR131","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/jnci\/93.20.1517","volume":"93","author":"K Garber","year":"2001","unstructured":"Garber, K. Rapamycin's resurrection: a new way to target the cancer cell cycle. J. Natl Cancer Inst. 93, 1517\u20131519 (2001).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnri1604_CR132","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S1471-4906(01)02118-4","volume":"23","author":"CV Ramana","year":"2002","unstructured":"Ramana, C. V., Gil, P. M., Schreiber, R. D. & Stark, G. R. Stat1-dependent and -independent pathways in IFN\u03b3-dependent signaling. Trends Immunol. 23, 96\u2013101 (2002).","journal-title":"Trends Immunol."},{"key":"BFnri1604_CR133","doi-asserted-by":"publisher","first-page":"7994","DOI":"10.1073\/pnas.0401593101","volume":"101","author":"N Sizemore","year":"2004","unstructured":"Sizemore, N. et al. Inhibitor of \u03baB kinase is required to activate a subset of interferon \u03b3-stimulated genes. Proc. Natl Acad. Sci. USA 101, 7994\u20137998 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnri1604_CR134","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655\u20131657 (2002).","journal-title":"Science"},{"key":"BFnri1604_CR135","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.immunol.22.012703.104721","volume":"22","author":"JA Deane","year":"2004","unstructured":"Deane, J. A. & Fruman, D. A. Phosphoinositide 3-kinase: diverse roles in immune cell activation. Annu. Rev. Immunol. 22, 563\u2013598 (2004).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnri1604_CR136","doi-asserted-by":"publisher","first-page":"723","DOI":"10.7326\/0003-4819-132-9-200005020-00007","volume":"132","author":"AH Malik","year":"2000","unstructured":"Malik, A. H. & Lee, W. M. Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann. Intern. Med. 132, 723\u2013731 (2000).","journal-title":"Ann. Intern. Med."},{"key":"BFnri1604_CR137","doi-asserted-by":"publisher","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","volume":"132","author":"TJ Liang","year":"2000","unstructured":"Liang, T. J., Rehermann, B., Seeff, L. B. & Hoofnagle, J. H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132, 296\u2013305 (2000).","journal-title":"Ann. Intern. Med."},{"key":"BFnri1604_CR138","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","volume":"290","author":"MR Loutfy","year":"2003","unstructured":"Loutfy, M. R. et al. Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study. JAMA 290, 3222\u20133228 (2003).","journal-title":"JAMA"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nri1604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1604","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nri1604.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T10:17:57Z","timestamp":1744366677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nri1604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,1]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5,1]]}},"alternative-id":["BFnri1604"],"URL":"https:\/\/doi.org\/10.1038\/nri1604","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,1]]},"assertion":[{"value":"The author declares no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}